Regional variations in the prevalence of major congenital malformations in quebec: The importance of fetal growth environment

Journal of Population Therapeutics and Clinical Pharmacology

Volumn 22, Issue 3, 2015, Pages e198-e210

  Zhao, Jin Ping ^a,b   Sheehy, Odile ^b   Bérard, Anick ^a,b  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MONTREAL   (Canada)

Author keywords

Fetal growth environment; Founder effect; Genetic predisposition; Major congenital malformations; Quebec pregnancy cohort; Regional variations

Indexed keywords

ARTICLE; CANADA; CONGENITAL HEART MALFORMATION; CONGENITAL MALFORMATION; FETUS GROWTH; GASTROINTESTINAL DISEASE; HUMAN; ICD-10; ICD-9; INFORMATION PROCESSING; MAJOR CLINICAL STUDY; MUSCULOSKELETAL DISEASE; NEUROLOGIC DISEASE; PREGNANCY; PREVALENCE; CONGENITAL ABNORMALITIES; FACTUAL DATABASE; FEMALE; FETUS DEVELOPMENT; HEART DEFECTS, CONGENITAL; MUSCULOSKELETAL ABNORMALITIES; NEWBORN; PHYSIOLOGY; PREGNANCY OUTCOME; QUEBEC;

CONGENITAL ABNORMALITIES; DATABASES, FACTUAL; FEMALE; FETAL DEVELOPMENT; HEART DEFECTS, CONGENITAL; HUMANS; INFANT, NEWBORN; MUSCULOSKELETAL ABNORMALITIES; PREGNANCY; PREGNANCY OUTCOME; PREVALENCE; QUEBEC;

EID: 84955160878     PISSN: 17106222     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Tennant PW, Pearce MS, Bythell M, Rankin J. 20-year survival of children born with congenital anomalies: a population-based study. Lancet 2010;375(9715):649-56.
2. Dastgiri S, Stone DH, Le-Ha C, Gilmour WH. Prevalence and secular trend of congenital anomalies in Glasgow, UK. Arch Dis Child 2002;86(4):257-63.
3. Public Health Agency of Canada. Congenital Anomalies in Canada 2013: A Perinatal Health Surveillance Report. Ottawa.
4. Nora JJ. Multifactorial inheritance hypothesis for the etiology of congenital heart diseases. The genetic-environmental interaction. Circulation 1968;38(3):604-17.
5. Dolk H, Loane M, Garne E. The prevalence of congenital anomalies in Europe. Adv Exp Med Biol 2010;686:349-64.
6. De Braekeleer M, Dao TN. Hereditary disorders in the French Canadian population of Quebec. I. In search of founders. Hum Biol 1994;66(2):205-23.
7. Scriver CR. Human genetics: lessons from Quebec populations. Annu Rev Genomics Hum Genet 2001;2:69-101.
8. Moreau C, Vezina H, Yotova V, et al. Genetic heterogeneity in regional populations of Quebec--parental lineages in the Gaspe Peninsula. Am J Phys Anthropol 2009;139(4):512-22.
9. De Braekeleer M. Geographic distribution of 18 autosomal recessive disorders in the French Canadian population of Saguenay-Lac-Saint-Jean, Quebec. Ann Hum Biol 1995;22(2):111-22.
10. Gagnon A, Heyer E. Fragmentation of the Quebec population genetic pool (Canada): evidence from the genetic contribution of founders per region in the 17th and 18th centuries. Am J Phys Anthropol 2001;114(1):30-41.
11. Choiniere R, Pageau M, Ferland M. Prevalence and geographic disparities in certain congenital anomalies in Quebec: comparison of estimation methods. Chronic Dis Can 1999;20(2):51-7.
12. Berard A, Sheehy O. The Quebec Pregnancy Cohort - prevalence of medication use during gestation and pregnancy outcomes. PLoS One 2014;9(4):e93870.
13. Nakhai-Pour HR, Broy P, Berard A. Use of antidepressants during pregnancy and the risk of spontaneous abortion. CMAJ 2010;182(10):1031-7.
14. Tamblyn R, Lavoie G, Petrella L, Monette J. The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Quebec. J Clin Epidemiol 1995;48(8):999-1009.
15. Levy AR, Mayo NE, Grimard G. Rates of transcervical and pertrochanteric hip fractures in the province of Quebec, Canada, 1981-1992. Am J Epidemiol 1995;142(4):428-36.
16. Berard A, Ramos E, Rey E, Blais L, St-Andre M, Oraichi D. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage. Birth Defects Res B Dev Reprod Toxicol 2007;80(1):18-27.
17. Ramos E, Oraichi D, Rey E, Blais L, Berard A. Prevalence and predictors of antidepressant use in a cohort of pregnant women. BJOG 2007;114(9):1055-64.
18. Ofori B, Rey E, Berard A. Risk of congenital anomalies in pregnant users of statin drugs. Br J Clin Pharmacol 2007;64(4):496-509.
19. Blais L, Berard A, Kettani FZ, Forget A. Validity of congenital malformation diagnostic codes recorded in Quebec's administrative databases. Pharmacoepidemiol Drug Saf 2013;22(8):881-9.
20. World Health Organization. International classification of diseases Ninth Revision (ICD-9). Geneva, 2010.
21. World Health Organization. International classification of diseases Tenth Revision (ICD-10). Geneva, 2010.
22. Vezina H, Durocher F, Dumont M, et al. Molecular and genealogical characterization of the R1443X BRCA1 mutation in high-risk French-Canadian breast/ovarian cancer families. Hum Genet 2005;117(2-3):119-32.
23. De Braekeleer M. Hereditary disorders in Saguenay-Lac-St-Jean (Quebec, Canada). Hum Hered 1991;41(3):141-6.
24. Torfs CP, Christianson RE. Maternal risk factors and major associated defects in infants with Down syndrome. Epidemiology 1999;10(3):264-70.
25. Hoffman JI, Kaplan S. The incidence of congenital heart disease. J Am Coll Cardiol 2002;39(12):1890-900.
26. Jennissen T. Political and Social Affairs Division. Health Issues in Rural Canada. Government of Canada Publications, December 1992.
27. Green RF, Devine O, Crider KS, et al. Association of paternal age and risk for major congenital anomalies from the National Birth Defects Prevention Study, 1997 to 2004. Ann Epidemiol 2010;20(3):241-9.
28. Martinez J, Pampalon R, Hamel D, Raymond G. Does living in rural communities rather than cities really make a difference in people's health and wellness? Institut National de Santé Publique du Québec, 2004.
29. Salem Yaniv S, Levy A, Wiznitzer A, Holcberg G, Mazor M, Sheiner E. A significant linear association exists between advanced maternal age and adverse perinatal outcome. Arch Gynecol Obstet 2011;283(4):755-9.
30. Murphy HR, Steel SA, Roland JM, et al. Obstetric and perinatal outcomes in pregnancies complicated by Type 1 and Type 2 diabetes: influences of glycaemic control, obesity and social disadvantage. Diabet Med 2011;28(9):1060-7.
31. Hillemeier MM, Weisman CS, Chase GA, Dyer AM. Mental health status among rural women of reproductive age: findings from the Central Pennsylvania Women’s Health Study. Am J Public Health 2008;98(7):1271-9.
32. Page AN, Swannell S, Martin G, Hollingworth S, Hickie IB, Hall WD. Sociodemographic correlates of antidepressant utilisation in Australia. Med J Aust 2009;190(9):479-83.
33. Berard A, Zhao JP, Sheehy O. Sertraline use during pregnancy and the risk of major malformations. Am J Obstet Gynecol 2015;212(6):795.e1-795.e12
34. O'Neill MS, Kinney PL, Cohen AJ. Environmental equity in air quality management: local and international implications for human health and climate change. J Toxicol Environ Health A 2008;71(9-10):570-7.
35. Statistiques: Accouchements et naissances. Ministère de la Santé et des Services sociaux. 2003;Governement de Quebec.